Peripheral neuropathy (PN) is a disabling side-effect of cancer itself and of neurotoxic chemotherapy, which is part of recommended treatment for colorectal cancer (CRC). The incidence of CRC is ri...

Psychologische zorg bij kanker

Background Adopting and maintaining favorable lifestyle changes can be challenging for postmenopausal breast cancer (PMBC) survivors. Understanding their experiences and needs can help tailor lifestyle support throughout their care journey. Purpose This qualitative study explored 1) perceived determinants relevant for favorable lifestyle change among PMBC survivors, 2) the needs and preferences of PMBC survivors regarding lifestyle support, and 3) perceived determinants relevant for preferred timing of lifestyle support among PMBC survivors. Methods A total of 42 in-depth longitudinal interviews were conducted at one year (n = 24) and 1.5 years (n = 21) following a breast cancer diagnosis. Data were analyzed using thematic analysis. Results Our analysis revealed 12 main themes: 1) 3 themes describe determinants that may affect the process of favorable lifestyle change (type of lifestyle behavior, previous attempts to change lifestyle, comorbidities), 2) 3 themes express PMBC survivors’ needs for lifestyle support from health care professionals (HCPs) (need for information, need for activation by lifestyle support, need for effective communication by HCPs), 3) 6 themes describe determinants influencing PMBC survivors’ preferred timing of addressing these needs (type of treatment, coping style, previous experience with cancer, personality, motivation for lifestyle change, social support). Conclusions Lifestyle support should consider psychological and physical effects of breast cancer diagnosis and treatment, which may hinder some PMBC survivors’ ability to make favorable lifestyle choices. Our results suggest that HCPs should offer ongoing individualized lifestyle support throughout the care continuum to meet the varied needs of PMBC survivors.

Objective This study explored eating disorder and Artificial Intelligence (AI) professionals' perspectives on how AI might support eating disorder treatment. Successful implementation requires insig...

Stress heeft een directe invloed op het hart en de bloedvaten. Zeker als je een hart- of vaataandoening hebt, is het belangrijk om er goed mee om te gaan. In deze online bijeenkomst helpen we je begrijpen wat er in je lichaam gebeurt bij stress...

The majority of patients with CHD do not report chronic depressed or fatigued symptoms. However, a substantial part does, and these symptoms may emerge after regular cardiac rehabilitation is finished.

Health literacy (HL) has been found to affect perceived information provision (PIP), satisfaction with information provision, and health-related quality of life (HRQoL) in patients with cancer. Patients with a rare cancer are confronted with challenges, such as a lack of information. The aim of this study was to explore the impact of HL on PIP, satisfaction with information provision, and on HRQoL in rare compared to common cancer patients.A population-based study was conducted using the PROFILES registry. Patients with rare (n = 385) and common (n = 1,692) cancer were included. Within group associations (low/medium HL, high HL, rare cancer, common cancer) were assessed. Regression analyses were used to assess associations between HL, PIP, satisfaction, and HRQoL, taking cancer group into account.Within the low/medium HL group, no statistically significant differences were found between rare and common cancer patients. Yet, within the high HL group, rare cancer patients scored significantly lower on all PIP-categories (except PIP-medical tests), satisfaction and HRQoL. Within the rare cancer group, patients with low/medium HL scored lower, compared to those with high HL, on PIP-medical tests and PIP-treatment, while within the common cancer group, patients with low/medium HL scored lower on all PIP-categories, satisfaction and HRQoL (all: p<0.05).Information needs might vary between patients with a different HL level and/or cancer group. Healthcare professionals should take individual needs into account, with a special focus on patients with a rare cancer and low/medium HL, in order to convey information in an understandable, patient-tailored way.

Placebo Effects in Neurology delves into the intriguing phenomenon of placebos and their profound impact on neurological disorders. This book explores